Cargando…
Improving the Pharmacodynamics and In Vivo Activity of ENPP1‐Fc Through Protein and Glycosylation Engineering
Enzyme replacement with ectonucleotide pyrophosphatase phospodiesterase‐1 (ENPP1) eliminates mortality in a murine model of the lethal calcification disorder generalized arterial calcification of infancy. We used protein engineering, glycan optimization, and a novel biomanufacturing platform to enha...
Autores principales: | Stabach, Paul R., Zimmerman, Kristin, Adame, Aaron, Kavanagh, Dillon, Saeui, Christopher T., Agatemor, Christian, Gray, Shawn, Cao, Wenxiang, De La Cruz, Enrique M., Yarema, Kevin J., Braddock, Demetrios T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877847/ https://www.ncbi.nlm.nih.gov/pubmed/33064927 http://dx.doi.org/10.1111/cts.12887 |
Ejemplares similares
-
ENPP1-Fc prevents mortality and vascular calcifications in rodent model of generalized arterial calcification of infancy
por: Albright, Ronald A., et al.
Publicado: (2015) -
Human Heterozygous ENPP1 Deficiency Is Associated With Early Onset Osteoporosis, a Phenotype Recapitulated in a Mouse Model of Enpp1 Deficiency
por: Oheim, Ralf, et al.
Publicado: (2019) -
Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified N-Acetylmannosamine (ManNAc) Analogs
por: Du, Jian, et al.
Publicado: (2021) -
Strategies for Glycoengineering Therapeutic Proteins
por: Dammen-Brower, Kris, et al.
Publicado: (2022) -
ENPP1-Fc prevents neointima formation in generalized arterial calcification of infancy through the generation of AMP
por: Nitschke, Yvonne, et al.
Publicado: (2018)